Danaher buys Cepheid for $4 billion in first deal since spinoff

Share

The company exchanged total volume of 6.15 million shares throughout course of last trade however it holds an average trading capacity of 3.42 million shares.

A pair of US -based 3-D printing companies traded higher after General Electric made a big bet on the industry. The company's market cap is $3.84 billion. Moving toward ratio analysis, it has current ratio of 0.70 and quick ratio was calculated as 0.70. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Let's have a look at some of the important valuation ratios of the CEPHEID (NASDAQ:CPHD). The consensus analyst estimate is actually $87.80, and this $95.00 target is a match against the highest analyst price target.

According to FactSet data, the stock has received different ratings from Financial Analysts. During the same quarter past year, the business posted ($0.06) EPS. The company expects the acquisition to be slightly dilutive to its GAAP EPS or accretive of about $0.05 in the first full year after acquisition. Cepheid has revealed that in 2016 it anticipates to generate $618 to $635 million in revenues. The company reported $0.05 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.14) by $0.19. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance.

Cepheid (NASDAQ:CPHD)'s stock was lowered to a "Hold" by research analysts at Craig Hallum.

While looking at the Stock's Performance, Danaher Corporation now shows a Weekly Performance of -2.86%, where Monthly Performance is -2.45%, Quarterly performance is 5.44%, 6 Months performance is 18.28% and yearly performance percentage is 23.3%. The company has inked a definitive agreement to buy molecular diagnostics company Cepheid CPHD for $53.00 per share.

REACTION: The biggest gains Tuesday went to utility and phone companies, and investors also snapped up government bonds, sending prices higher and yields lower.

Cepheid (NASDAQ:CPHD) last posted its quarterly earnings results on Thursday, July 28th.

In the prior 12 months Danaher Corporation's stock price has increased by 0% from 0.00 to 79.5. Similar, the positive performance for the quarter recorded as 81.80% and for the year was 1.54%, while the YTD performance remained at 44.13%. It maintained return on assets (ROA) for the last twelve months at 48.31%. The latest offer values Monsanto at around $55.8 billion, or about $1 billion more than Bayer had offered preciously.

The average true range of Danaher Corp.'s (DHR) is recorded at 0.82 and the relative strength index of the stock stands 35.33.

Share